Adaptive Biotechnologies Corporation (ADPT)
Company Info
| ISIN | US00650F1093 |
|---|---|
| CUSIP | 00650F109 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $36.95M |
|---|---|
| EPS | $0.14 |
| PE Ratio | 81.14 |
| EBITDA (TTM) | -$171.43M |
| Year Range | $10.16 - $15.18 |
| Target Price | $9.17 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of $10,000 in Adaptive Biotechnologies Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Popular comparisons: ADPT vs. SPY
Return
Adaptive Biotechnologies Corporation had a return of -39.53% year-to-date (YTD) and -41.00% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -39.53% | 18.49% |
| 1 month | -3.75% | 4.20% |
| 6 months | -39.53% | 6.60% |
| 1 year | -41.00% | 15.43% |
| 5 years (annualized) | N/A | 11.59% |
| 10 years (annualized) | N/A | 9.70% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -2.52% | -3.59% | 25.78% | -19.79% | -19.50% | -18.53% | -1.35% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Adaptive Biotechnologies Corporation (ADPT) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
ADPT Adaptive Biotechnologies Corporation | -0.58 | ||||
^GSPC S&P 500 | 1.00 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Adaptive Biotechnologies Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Adaptive Biotechnologies Corporation was 94.90%, occurring on Nov 13, 2023. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -94.9% | Jan 25, 2021 | 707 | Nov 13, 2023 | — | — | — |
| -68.3% | Sep 5, 2019 | 133 | Mar 16, 2020 | 188 | Dec 10, 2020 | 321 |
| -27.29% | Jul 1, 2019 | 25 | Aug 5, 2019 | 18 | Aug 29, 2019 | 43 |
| -14.85% | Dec 24, 2020 | 7 | Jan 5, 2021 | 7 | Jan 14, 2021 | 14 |
| -2.05% | Dec 15, 2020 | 1 | Dec 15, 2020 | 2 | Dec 17, 2020 | 3 |
Volatility Chart
The current Adaptive Biotechnologies Corporation volatility is 34.71%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.